Prototribestin

Prototribestin at a Glance

Prototribestin is a sulfated furostanol saponin — a large steroidal glycoside, C₄₅H₇₃NaO₂₁S, molecular weight ~1,005 Da as the sodium salt (PubChem CID 172641540; CAS 425407-43-8). It was isolated in 2002 from the aerial parts of Tribulus terrestris growing in Bulgaria, alongside its 22-O-methyl relative methylprototribestin, in a paper that described both as new ^{1Reference 1Kostova I et al. · 2002Two new sulfated furostanol saponins from Tribulus terrestrisView study →}.

Two things make it worth a page, and neither is a pharmacological effect.

First, the sulfate group. Almost all steroidal saponins are neutral glycosides; prototribestin carries a sulfate ester on the 4-position of its inner glucose, which makes it an anionic molecule and a genuine rarity. It shows up in surveys of sulfur-containing plant metabolites — a category otherwise dominated by the glucosinolates of the cabbage family — clustered with the handful of other sulfated saponins known from plants ^{8Reference 8Abdullah-Zawawi MR et al. · 2022Chemoinformatics-driven classification of Angiosperms using sulfur-containing compounds and machine learning algorithmView study →}.

Second, and this is the reason the page exists: it is a geographic marker. When Bulgarian, Greek, Serbian, Macedonian, Turkish, Georgian, Iranian, Vietnamese and Indian T. terrestris were profiled side by side, prototribestin was one of the two main saponins in every European and West Asian sample and was completely absent from the Vietnamese and Indian ones ^{2Reference 2Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →}. That presence/absence line is the sharpest chemotaxonomic split published for this plant — and it maps directly onto the origin claim the entire tribulus supplement category leans on.

What it does not have is a pharmacology. Not a receptor, not an enzyme, not an animal study, not a cell assay. Everything below is either analytical chemistry about this molecule, or pharmacology that belongs to something else.

The Whole Literature, In One Table

Most compound pages summarise a literature. This one can print it. As of August 2026, PubMed returns three records for prototribestin — all three about Tribulus terrestris, and all three analytical. Broadening to a full-text search (Europe PMC) raises the total to nine, of which four are reviews restating the same chemotype finding.

Year	Study	What it did with prototribestin	Ref
2002	Kostova et al.	Isolated and structurally characterised it (NMR + ESI-MS) from Bulgarian aerial parts	1Reference 1Kostova I et al. · 2002Two new sulfated furostanol saponins from Tribulus terrestrisView study →
2008	Dinchev et al.	Quantified it by LC-ESI/MS/MS across nine countries — the chemotype paper	2Reference 2Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →
2011	Kozlova et al.	Detected it by HPLC in commercial tribulus food supplements	4Reference 4Kozlova OI et al. · 2011Determination by high performance chromatography of steroid saponins in biologically active food supplements containing the extract of Tribulus terrestris [in Russian]View study →
2025	Gođevac et al.	Used it as one of five authenticity markers in an anti-adulteration metabolomics model	5Reference 5Gođevac D et al. · 2025LC-MS-based metabolomics for detecting adulteration in Tribulus terrestris-derived dietary supplementsView study →
2022	Abdullah-Zawawi et al.	Included it in a sulfur-containing-metabolite clustering of 692 plant species	8Reference 8Abdullah-Zawawi MR et al. · 2022Chemoinformatics-driven classification of Angiosperms using sulfur-containing compounds and machine learning algorithmView study →
2024	Kuvendziev et al.	Named it among the extract’s compounds of interest in an extraction-optimisation study	12Reference 12Kuvendziev S et al. · 2024ANN modeling and RSM optimization of ultrasound-assisted extraction of protodioscin-rich extracts from Tribulus terrestris LView study →

Four reviews ^{6,7Reference 6Ștefănescu R et al. · 2020ReviewA comprehensive review of the phytochemical, pharmacological, and toxicological properties of Tribulus terrestris LView study →Reference 7Zhu W et al. · 2017ReviewA review of traditional pharmacological uses, phytochemistry, and pharmacological activities of Tribulus terrestrisView study →} and two further papers repeat these findings without adding data. There is no bioassay of prototribestin anywhere in that list — no cytotoxicity, no receptor binding, no enzyme inhibition, no animal work, no human exposure study. A molecule with three primary records has not been shown to be active or inactive; it has simply never been tested.

Why It Matters: The Bulgarian Chemotype Marker

Tribulus supplements are sold on a provenance claim. “Bulgarian tribulus” is the premium designation, and it exists because the Bulgarian standardised extract Tribestan is the material behind most of the herb’s real clinical evidence — including the well-powered 12-week randomised trial that found benefit on the International Index of Erectile Function ^{9Reference 9Kamenov Z et al. · 2017RCTEvaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction — a prospective, randomized, double-blind, placebo-controlled clinical trialView study →}. Everything downstream of that trial assumes the product in the bottle resembles the product in the study.

Prototribestin is the cleanest chemical test of that assumption available, because its distribution is binary, not merely variable.

In the 2008 survey, samples from Bulgaria, Turkey, Greece, Serbia, Macedonia, Georgia and Iran all shared one chemical profile, with protodioscin and prototribestin as the two dominant components. The Vietnamese and Indian samples showed a completely different profile: they lacked prototribestin and its spirostanol partner tribestin entirely, while carrying high levels of tribulosin instead — and compounds not among the seven markers dominated their extracts altogether ^{2Reference 2Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →}. The authors concluded that a single chemotype spans southeastern Europe and western Asia, and that the Indian and Vietnamese plants belong to other, still-uncharacterised chemotypes.

This is a stronger discriminator than protodioscin, which is the marker the industry actually uses. Protodioscin is present nearly everywhere — it simply varies in amount, by more than twenty-fold, so a low number is ambiguous between “wrong origin”, “wrong plant part”, “wrong season” and “poor extraction” ^{2,6Reference 2Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →Reference 6Ștefănescu R et al. · 2020ReviewA comprehensive review of the phytochemical, pharmacological, and toxicological properties of Tribulus terrestris LView study →}. Prototribestin is either there or it is not. A tribulus extract that contains prototribestin came from European or West Asian material; one that contains none did not, whatever the label says.

The idea has since been used in exactly that way. A 2025 LC-HRMS metabolomics study built to detect adulterated T. terrestris supplements found that prototribestin was one of five metabolites — with protodioscin, neoprotodioscin, rutin and N-trans-feruloyltyramine — that most strongly distinguished authentic plant material from commercial products in the discriminant model ^{5Reference 5Gođevac D et al. · 2025LC-MS-based metabolomics for detecting adulteration in Tribulus terrestris-derived dietary supplementsView study →}. The same study found products spiked with PDE5 inhibitors and anabolic steroids, and others cut with undisclosed green tea and citrus compounds. Prototribestin survives into finished supplements and is detectable there by routine HPLC ^{4Reference 4Kozlova OI et al. · 2011Determination by high performance chromatography of steroid saponins in biologically active food supplements containing the extract of Tribulus terrestris [in Russian]View study →}, so this is a practical test, not a theoretical one.

The honest limit of the claim: nobody has shown that the European chemotype works better because it contains prototribestin. Prototribestin is a fingerprint, not an active. It happens to travel with the material the trials used. Those are different arguments, and the second one has never been tested.

What It's Used For

Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. Note what the rows are: the only well-supported use of this molecule is analytical. The two pharmacological rows score low because neither finding actually belongs to prototribestin. Each application links to its write-up.

01Chemotype & Authenticity MarkerPromising72%A nine-country LC-MS/MS survey plus independent use in an anti-adulteration model ^{2,5Reference 2Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →Reference 5Gođevac D et al. · 2025LC-MS-based metabolomics for detecting adulteration in Tribulus terrestris-derived dietary supplementsView study →}

02Multidrug-Resistance ReversalShaky8%One in-vitro screen — of methylprototribestin, a different molecule ^{3Reference 3Ivanova A et al. · 2009AnimalScreening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulatorsView study →}

03Male Sexual FunctionShaky6%Whole-extract randomised trials of furostanol-standardised tribulus; no molecule-level data ^{9Reference 9Kamenov Z et al. · 2017RCTEvaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction — a prospective, randomized, double-blind, placebo-controlled clinical trialView study →}

Mechanisms

There is no mechanism table for this molecule in the ordinary sense, because no target has been reported. What can honestly be tabulated is the structural chemistry and who owns which claim.

Target / property	What is known	Whose finding
Any receptor, enzyme or transporter	Nothing reported	—
P-glycoprotein (MDR reversal)	Most effective modifier in a tribulus saponin panel	Methylprototribestin, not prototribestin 3Reference 3Ivanova A et al. · 2009AnimalScreening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulatorsView study →
Cell growth inhibition	ID₅₀ 12.6–20.6 µg/mL across the panel; no normal-cell selectivity index	Panel-level, sibling molecules 3Reference 3Ivanova A et al. · 2009AnimalScreening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulatorsView study →
NO/cGMP cavernosal relaxation	Proposed mechanism for tribulus extract	Attributed to protodioscin; not tested for this molecule 9Reference 9Kamenov Z et al. · 2017RCTEvaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction — a prospective, randomized, double-blind, placebo-controlled clinical trialView study →
Chemotype discrimination	Present in European/West Asian material, absent in Indian/Vietnamese	Prototribestin’s own, well replicated 2,5Reference 2Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →Reference 5Gođevac D et al. · 2025LC-MS-based metabolomics for detecting adulteration in Tribulus terrestris-derived dietary supplementsView study →
Membrane surfactancy	Expected class property of a steroidal saponin; never measured for this compound	Class inference

Pharmacokinetics

There is no pharmacokinetic study of prototribestin. Not in humans, not in animals, not in a cell monolayer. What follows is class reasoning and should be read as such.

At ~1,005 Da, with three sugars, a sulfate ester and a dozen free hydroxyls, prototribestin sits far outside the range for passive intestinal absorption. Steroidal saponins of this size are poorly bioavailable as intact glycosides; the species that generally reaches tissue is the deglycosylated sapogenin, liberated by gut microbiota — dioscin and protodioscin both funnel to diosgenin this way. Prototribestin’s aglycone is the same diosgenin skeleton, so on that logic the systemically available product of eating it is not prototribestin at all.

The sulfate group is an unstudied wrinkle in that story: it makes the molecule anionic and more water-soluble than a neutral saponin, and it is a plausible substrate for bacterial sulfatases, but nobody has looked. Whether prototribestin is desulfated first, deglycosylated first, or excreted intact is genuinely unknown.

Clinical Trials

None. There are no clinical trials of prototribestin, and no registered study of it under any name. Human exposure is entirely incidental, through tribulus extracts made from European plant material.

Last checked: August 2026.

Furostanol vs. Spirostanol: Why Processing Changes The Answer

This distinction is not pedantry, and it matters for anyone reading a certificate of analysis.

Furostanol saponins like prototribestin have an open F ring, held open by a sugar on the C-26 hydroxyl and a free hydroxyl at C-22. Remove that C-26 glucose — by enzyme, acid, heat or simply slow drying — and the ring snaps shut into the spirostanol form. Prototribestin’s spirostanol counterpart is tribestin, and the pair behave exactly as that relationship predicts: in the nine-country survey both were present together in European material and both were absent together from Indian and Vietnamese material, with tribestin generally — but not uniformly — the lesser of the two. The averaged picture hides real inversions: in Serbian material tribestin reaches 210 mg/100 g against prototribestin’s 170, making it the most abundant of all seven markers measured, and the primary names tribestin the main component of aerial parts from both Pomorie (Bulgaria) and Niš (Serbia) ^{2,6Reference 2Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →Reference 6Ștefănescu R et al. · 2020ReviewA comprehensive review of the phytochemical, pharmacological, and toxicological properties of Tribulus terrestris LView study →}.

Three practical consequences follow. Handling changes the number: a sample dried slowly or extracted warm converts furostanols to spirostanols, so a low prototribestin reading can reflect processing rather than provenance. The forms are not interchangeable: they differ in polarity, water solubility and chromatographic behaviour, and a method validated for one will not quantify the other. And “standardised to furostanol saponins” — the phrasing on Tribestan and on much of the category — is a class specification. It tells you the sum, not the composition, and a product could in principle hit a furostanol number on protodioscin alone with no prototribestin at all.

The Diosgenin Myth, And Where This Molecule Sits

Prototribestin’s aglycone is diosgenin — the same steroidal sapogenin at the core of wild yam, fenugreek and protodioscin. That fact is the origin of the most repeated false claim in this entire supplement category, so it is worth stating plainly here.

Diosgenin was the industrial feedstock from which progesterone and cortisone were historically semi-synthesised, by the Marker degradation. That is a multi-step chemical process involving acetic anhydride, chromium oxidation and pyrolysis in a factory. The human body cannot do it. There is no human enzyme that converts diosgenin to progesterone, DHEA or testosterone. “Wild yam converts to progesterone” is false; topical “natural progesterone” creams that do something contain added progesterone.

For prototribestin specifically the implication is direct: carrying a diosgenin skeleton confers no hormonal activity whatsoever. And this matters more for tribulus than for most herbs, because tribulus is marketed almost entirely as a testosterone booster — a claim that controlled human trials have repeatedly failed to support, including for the standardised Bulgarian extract, even where sexual function improved ^{9Reference 9Kamenov Z et al. · 2017RCTEvaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction — a prospective, randomized, double-blind, placebo-controlled clinical trialView study →}. The herb’s genuine sexual-function signal is not an androgen effect. Nothing about prototribestin’s structure changes that, and nothing in its (empty) pharmacological record suggests direct hormonal activity of any kind.

Isolate vs. Plant

The boundary here is unusually easy to police, because there is nothing on the isolate side to confuse.

Every published number for prototribestin is a concentration in a plant, not a potency in an assay. Every biological claim in its vicinity belongs to something else: the whole Tribestan extract ^{9Reference 9Kamenov Z et al. · 2017RCTEvaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction — a prospective, randomized, double-blind, placebo-controlled clinical trialView study →}, the total furostanol saponin fraction, or the sibling molecule methylprototribestin ^{3Reference 3Ivanova A et al. · 2009AnimalScreening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulatorsView study →}. This page therefore makes no isolate claim at all, and any page or product that attributes an effect to prototribestin is going beyond the literature.

Reading in the other direction — from the molecule to the herb — the only supportable inference is the analytical one: prototribestin’s presence tells you where the plant grew, and by proxy whether it resembles the material used in the trials ^{2,5Reference 2Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →Reference 5Gođevac D et al. · 2025LC-MS-based metabolomics for detecting adulteration in Tribulus terrestris-derived dietary supplementsView study →}. That is a real and useful inference. It is not a pharmacological one.

Natural Sources

Prototribestin has not been reported from any plant outside Tribulus terrestris. A full-text search returns nine records and all nine concern that species; a systematic survey of sulfur-containing metabolites across 692 plant species lists it only from Tribulus ^{8Reference 8Abdullah-Zawawi MR et al. · 2022Chemoinformatics-driven classification of Angiosperms using sulfur-containing compounds and machine learning algorithmView study →}. Attribution check: prototribestin AND "Tribulus terrestris" returns 3 of 3 PubMed records — the herb attribution in our database is correct and complete.

Concentrations below are compiled in a 2020 review from the underlying analytical papers — the 2002 isolation work ^{1Reference 1Kostova I et al. · 2002Two new sulfated furostanol saponins from Tribulus terrestrisView study →}, the nine-country survey ^{2Reference 2Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →}, an intraspecific-variability study in south Bulgaria ^{10Reference 10Lazarova I et al. · 2011Intraspecific variability of biologically active compounds of different populations of Tribulus terrestris L. (Zygophyllaceae) in South BulgariaView study →} and an independent Italian analysis of tribulus furostanols ^{11Reference 11De Combarieu E et al. · 2003Furostanol saponins from Tribulus terrestrisView study →} — expressed as mg per 100 g dry weight ^{6Reference 6Ștefănescu R et al. · 2020ReviewA comprehensive review of the phytochemical, pharmacological, and toxicological properties of Tribulus terrestris LView study →}.

Origin	Plant part	mg/100 g DW	% dry wt
Bulgaria	Aerial parts	130–2,200	0.13–2.2%
Bulgaria	Leaves	700	0.70%
Bulgaria	Stems	40	0.04%
Bulgaria	Fruits	21–28	0.021–0.028%
Turkey	Aerial parts	310–1,000	0.31–1.0%
Turkey	Fruits	17–65	0.017–0.065%
Georgia	Aerial parts	240	0.24%
Serbia	Aerial parts	170	0.17%
Greece · Macedonia	Aerial parts	see note	—
Vietnam · India	Aerial parts, fruits	not detected	0%

A data caveat, stated because it is checkable: in that review’s table the Greek (220–790) and Macedonian (420–990) figures for prototribestin are identical to the figures given one row above for protodioscin, which is almost certainly a transcription error in the compilation rather than a real coincidence across two compounds and two countries. Both countries are reported as prototribestin-containing in the primary paper ^{2Reference 2Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →}; the specific numbers should not be quoted until the original table is checked.

Two patterns are robust across the dataset. Leaves carry the saponin load — stems and fruits run an order of magnitude lower, so a fruit-only or whole-plant preparation is a weaker starting material than a leafy aerial-parts harvest. And the range within Bulgaria alone spans about seventeen-fold, which is why intraspecific variability between populations in a single region has needed its own study ^{10Reference 10Lazarova I et al. · 2011Intraspecific variability of biologically active compounds of different populations of Tribulus terrestris L. (Zygophyllaceae) in South BulgariaView study →}. Origin sets whether the molecule is there at all; everything after that is agronomy.

Discovery & Synthesis

Prototribestin was described in 2002 by Irena Kostova, Dimitar Dinchev, G.H. Rentsch, Vladimir Dimitrov and Aneliya Ivanova at the Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences. Working on the aerial parts of Bulgarian T. terrestris, they isolated the already-known furostanols methylprotodioscin and protodioscin together with two new sulfated saponins: methylprototribestin and prototribestin. Structures were solved by 1D and 2D NMR (DQF-COSY, TOCSY, HSQC-TOCSY, HSQC, HMBC, ROESY), ESI mass spectrometry and chemical transformation ^{1Reference 1Kostova I et al. · 2002Two new sulfated furostanol saponins from Tribulus terrestrisView study →}.

Systematically it is the sodium salt of 26-O-β-D-glucopyranosyl-22α-hydroxy-(25R)-furost-5-ene-3β,26-diol 3-O-α-L-rhamnopyranosyl-(1→2)-β-D-4-O-sulfo-glucopyranoside — that is, a diosgenin-type aglycone in its open furostanol form, glucose on C-26, and a rhamnose–glucose disaccharide on C-3 with the sulfate ester on the glucose 4-position. Methylprototribestin is the same molecule with a methyl ether at C-22 instead of the free hydroxyl. The name follows the house convention of the group: the proto- prefix marks the furostanol (open-ring) precursor of the corresponding spirostanol, tribestin, exactly as protodioscin relates to dioscin.

There is no total synthesis, no commercial preparation and no analytical reference standard in general circulation — a practical obstacle to using it as a routine authenticity marker, and part of why the industry standardises on protodioscin instead. All published material came from column chromatography of plant extract. Patents: not yet researched.

Toxicity & Safety

The honest verdict is not characterised, and the unknown grading is literal. There has been no toxicology study of prototribestin of any kind — no acute toxicity, no genotoxicity, no reproductive study, no haemolysis assay, no animal experiment. It has never been administered to anything.

That is not the same as a clean record. Steroidal saponins as a class are membrane-active surfactants, and Tribulus terrestris itself has real toxicology attached to it: the spirostanol terrestrosin D has been implicated in hepatorenal toxicity in rats, and grazing livestock develop a well-documented locomotor syndrome on the plant. None of that has been traced to prototribestin, and none of it has been ruled out either.

Safety at a Glance

❔ Toxicity unknown

• No adverse effect has ever been attributed to prototribestin. It has also never been tested — those are different statements.
• Long incidental human exposure. Bulgarian tribulus preparations rich in this saponin have been consumed for decades without a signal specific to it ^{9Reference 9Kamenov Z et al. · 2017RCTEvaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction — a prospective, randomized, double-blind, placebo-controlled clinical trialView study →}.
• Zero toxicology data. No acute, genotoxic, haemolytic or reproductive study exists. The unknown grading is a description of the literature, not reassurance.
• No reproductive or developmental data. Nothing is known about use in pregnancy or breastfeeding; the parent herb is conventionally avoided in pregnancy, and that caution carries over.
• Saponins are membrane-active. As a surfactant glycoside it should be assumed haemolytic in vitro until measured, and any concentrated, injected or nanoformulated preparation treated as an unknown.
• The parent herb carries its own toxicology. Tribulus has documented hepatorenal signals in rodents and a locomotor syndrome in grazing sheep; the responsible molecules are other saponins and alkaloids, but the plant-level caution is real.
• A “Bulgarian tribulus” label is not a safety guarantee. The same authentication study that found prototribestin useful as a marker also found commercial products spiked with PDE5 inhibitors and anabolic steroids ^{5Reference 5Gođevac D et al. · 2025LC-MS-based metabolomics for detecting adulteration in Tribulus terrestris-derived dietary supplementsView study →}.

Full Safety & Interactions Detail

No adverse effect specific to prototribestin has been reported, and no study has been designed to find one — the entire primary literature is three analytical papers ^{1,2,4Reference 1Kostova I et al. · 2002Two new sulfated furostanol saponins from Tribulus terrestrisView study →Reference 2Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →Reference 4Kozlova OI et al. · 2011Determination by high performance chromatography of steroid saponins in biologically active food supplements containing the extract of Tribulus terrestris [in Russian]View study →}.

What can be reasoned about is class behaviour and plant-level context. As a ~1,005 Da sulfated glycoside it is very unlikely to be absorbed intact, which limits systemic exposure to the intact molecule but places it, like other saponins, in the gut lumen where surfactant effects (irritation, altered membrane permeability, possible enhanced absorption of co-administered compounds) are the plausible local actions. None has been measured for this compound.

At the herb level, Tribulus terrestris is not a benign plant in every context: a 28-day rat study and in-vitro work implicate the spirostanol terrestrosin D in hepatorenal toxicity, β-carboline alkaloids (harman, harmine) occur in trace and variable amounts and are implicated in the locomotor “staggers” syndrome of grazing sheep, and isolated case reports of hepatotoxicity and nephrotoxicity attach to tribulus products. None of this is prototribestin’s, and it would be wrong to transfer it — but it is the reason not to read “no data” as “no risk”.

The most concrete practical hazard in this molecule’s vicinity is adulteration, not toxicity. The 2025 metabolomics survey of commercial tribulus supplements confirmed PDE5 inhibitors and anabolic steroids in spiked samples and undisclosed green tea and citrus constituents in some products, and flagged spirost-4-ene-3,12-dione as a marker of steroidal saponin degradation during storage or processing ^{5Reference 5Gođevac D et al. · 2025LC-MS-based metabolomics for detecting adulteration in Tribulus terrestris-derived dietary supplementsView study →}.

For a category bought for a hormonal claim it cannot deliver, that is the risk worth attending to. There is no reproductive or developmental data on prototribestin or, adequately, on tribulus.

Dosage

There is no dose. Prototribestin has never been administered to a human being or an animal as an isolate, and no dosing study exists to extrapolate from. Every published figure is a concentration in a plant, not an intake.

Real-world exposure comes only from tribulus preparations, and its size there is set almost entirely by where the plant grew. A European or West Asian aerial-parts extract can carry it at up to ~2.2% of dry plant weight — comparable to or greater than protodioscin in the same material ^{2,6Reference 2Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →Reference 6Ștefănescu R et al. · 2020ReviewA comprehensive review of the phytochemical, pharmacological, and toxicological properties of Tribulus terrestris LView study →}. An Indian or Vietnamese preparation carries none ^{2Reference 2Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →}. Neither figure is a recommendation, and no clinical claim here rests on either.

For what the herb itself has actually been studied at, see tribulus.

References

1. Kostova I, Dinchev D, Rentsch GH, Dimitrov V, Ivanova A (2002). Two new sulfated furostanol saponins from Tribulus terrestris. Zeitschrift für Naturforschung C 57:33–38. https://pubmed.ncbi.nlm.nih.gov/11926540/
2. Dinchev D, Janda B, Evstatieva L, Oleszek W, Aslani MR, Kostova I (2008). Distribution of steroidal saponins in Tribulus terrestris from different geographical regions. Phytochemistry 69:176–186. https://pubmed.ncbi.nlm.nih.gov/17719068/
3. Ivanova A, Serly J, Dinchev D, Ocsovszki I, Kostova I, Molnar J (2009). Screening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulators. In Vivo 23:545–550. https://pubmed.ncbi.nlm.nih.gov/19567388/
4. Kozlova OI, Perederiaev OI, Ramenskaia GV (2011). Determination by high performance chromatography of steroid saponins in biologically active food supplements containing the extract of Tribulus terrestris [in Russian]. Voprosy Pitaniia 80:67–71. https://pubmed.ncbi.nlm.nih.gov/22379868/
5. Gođevac D, Jeremić JS, Cvetković M, Simić K, Sofrenić I, Ljujić J, Popović L, Gašić U, Hoang YN, Huan T, Ivanović S (2025). LC-MS-based metabolomics for detecting adulteration in Tribulus terrestris-derived dietary supplements. Food Chemistry: X 27:102476. https://pubmed.ncbi.nlm.nih.gov/40290465/
6. Ștefănescu R, Tero-Vescan A, Negroiu A, Aurică E, Vari CE (2020). A comprehensive review of the phytochemical, pharmacological, and toxicological properties of Tribulus terrestris L. Biomolecules 10:752. https://pubmed.ncbi.nlm.nih.gov/32408715/
7. Zhu W, Du Y, Meng H, Dong Y, Li L (2017). A review of traditional pharmacological uses, phytochemistry, and pharmacological activities of Tribulus terrestris. Chemistry Central Journal 11:60. https://pubmed.ncbi.nlm.nih.gov/29086839/
8. Abdullah-Zawawi MR, Govender N, Karim MB, Altaf-Ul-Amin M, Kanaya S, Mohamed-Hussein ZA (2022). Chemoinformatics-driven classification of Angiosperms using sulfur-containing compounds and machine learning algorithm. Plant Methods 18:118. https://pubmed.ncbi.nlm.nih.gov/36335358/
9. Kamenov Z, Fileva S, Kalinov K, Jannini EA (2017). Evaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction — a prospective, randomized, double-blind, placebo-controlled clinical trial. Maturitas 99:20–26. https://pubmed.ncbi.nlm.nih.gov/28364864/
10. Lazarova I, Ivanova A, Mechkarova P, Peev D, Valyovska N (2011). Intraspecific variability of biologically active compounds of different populations of Tribulus terrestris L. (Zygophyllaceae) in South Bulgaria. Biotechnology & Biotechnological Equipment 25:2352–2356. https://doi.org/10.5504/BBEQ.2011.0040
11. De Combarieu E, Fuzzati N, Lovati M, Mercalli E (2003). Furostanol saponins from Tribulus terrestris. Fitoterapia 74:583–591. https://doi.org/10.1016/S0367-326X(03)00152-7
12. Kuvendziev S, Dimitrievska I, Stojchevski M, Marinkovski M (2024). ANN modeling and RSM optimization of ultrasound-assisted extraction of protodioscin-rich extracts from Tribulus terrestris L. Ultrasonics Sonochemistry 111:107141. https://pubmed.ncbi.nlm.nih.gov/39531938/

View all 12 references▾